First Header Logo Second Header Logo

Potential cost savings of erythropoietin administration in end-stage renal disease.

Hynes DM, Stroupe KT, Greer JW, Reda DJ, Frankenfield DL, Kaufman JS, Henderson WG, Owen WF, Rocco MV, Wish JB, Kang J, Feussner JR. Potential cost savings of erythropoietin administration in end-stage renal disease. Am J Med. 2002 Feb 15; 112(3):169-75.

View in: PubMed